PATENT CLAIM ANALYSIS

Application Number: 16051863
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "252010"]

Abstract:
Compounds of Formula I are described as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need are also disclosed.

Claim (Index 59):
The method according to  claim 58  wherein the neurological or psychiatric disorder is depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, a movement disorder, epilepsy, autism or cognitive impairments.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15663688', '15819372', '16018496', '11018019', '13820598']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8175856634993389
- 35 USC 102 Novelty (BERT): 0.5397291849043074
- Combined Prediction Score: 0.7898000156398358
- Mean Citation Score: 280.443038
- Max Citation Score: 298.94733
- Similarity Product: 200.2430954618776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test